This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Clinicians and researchers interested in Alzheimer disease (AD) are confronted with an expanding number of biomarkers that can be derived from brain imaging and CSF analysis. But how do we make sense of specific and nonspecific disease indicators that increasingly coexist in normal and diseased older people? In this issue of Neurology®, Jack et al.1 present us with a scheme that indicates the binary presence or absence of 7 biomarkers in 3 categories of amyloid (A), tau (T), and neurodegeneration (N): the A/T/N classification system. The rationale for such a new descriptive system for categorizing multidomain biomarkers is 4-fold: (1) the advent of tau PET tracers providing an imaging biomarker of tau neuropathology; (2) the uncertainty regarding the temporal relationships among current β-amyloid (Aβ) and tau biomarkers; (3) independence from diagnostic classification schemes that are not directly related to biomarkers, particularly independence from diagnostic classification based on cognition; and (4) the need to include all biomarker profiles that are found in all members of the population. The rationale is laudable, but how far does the proposed A/T/N classification scheme go toward achieving this?
Footnotes
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the author, if any, are provided at the end of the editorial.
See page 539
- © 2016 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.